Book a demo

Chemical intelligence powered by cypris.ai

Flanin

[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate · also: Flavol, Bisulase, riboflavin, Flavomononucleotide, Flavinmononucleotid, flavin mononucleotide

FormulaC17H21N4O9P
Mol. weight456.3478
PubChem CID643976
InChIKeyFVTCRASFADXXNN-SCRDCRAPSA-N
SMILESCC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O
17,442Patents
3,126Research papers
1,102Patents - last 3 years
91Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1BASF SE389
2MJN US Holdings LLC245
3Rohto Pharmaceutical Co Ltd232
4Bayer Corp160
5AstraZeneca AB114
6DSM IP Assets BV113
7Ajinomoto Co Inc96
8Takeda Pharmaceutical Co Ltd88
9Cima Labs Inc85
10EIDP Inc85

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations5,948
2A61PTherapeutic activity (drug indications)4,852
3C12NMicroorganisms, enzymes4,361
4G01NInvestigating / analysing materials2,751
5C12PFermentation, enzyme processes2,265
6C07KPeptides2,086
7C12QMeasuring/testing involving enzymes1,935
8A23LFoods and beverages (general)1,580
9C07DHeterocyclic compounds1,454
10C12YEnzyme nomenclature (EC numbers)1,428

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Most-cited patents

Patents ranked by forward citations reveal the foundational inventions the field continues to build on.

TitleYearAssigneeCited by
Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae1999Iowa State University Research Foundation Inc ISURF40
Bacterial strains which overproduce riboflavin1998DSM IP Assets BV31
MEDICINE COMPOSITION CONTAINING RIBOFLAVIN-BASED COMPOUND2004Eisai Co Ltd23
Riboflavin-linked assay procedures and materials1988London Biotechnology Limited23
High-yield riboflavin Escherichia coli engineering strain, and construction and fermentation method thereof2016TIANJIN UNIVERSITY22

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1bioluminescence and chemiluminescence research11
2Photosynthetic Processes and Mechanisms8
3Amino Acid Enzymes and Metabolism7
4Pharmacogenetics and Drug Metabolism6
5Enzyme Structure and Function5
6Metabolism and Genetic Disorders4
7Nitric Oxide and Endothelin Effects4
8Light effects on plants3
9Molecular Sensors and Ion Detection3
10Polyamine Metabolism and Applications3

Technology trend analysis

Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.

See Cypris in action

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Gordon TollinUniversity of Arizona37
2Stephen G. MayhewUniversity College Dublin35
3Adelbert BacherTechnical University of Munich25
4Vincent MasseyUniversity of Michigan21
5J. Woodland HastingsHarvard University20
6Nigel S. ScruttonUniversity of Manchester18
7Changjian FengUniversity of New Mexico17
8Donald B. McCormickCornell University16
9Franz MüllerGraduate School Experimental Plant Sciences14
10Andrew W. MunroUniversity of Strathclyde12

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of Flanin?

Flanin has the molecular formula C17H21N4O9P and a molecular weight of 456.3478. It is also known by several synonyms including riboflavin monophosphate, flavin mononucleotide, and riboflavine dihydrogen phosphate.

Which organizations hold the most patents related to Flanin?

BASF SE leads with 389 patents, followed by MJN US Holdings LLC with 245 patents and Rohto Pharmaceutical Co Ltd with 232 patents. Other major patent holders include Bayer Corp, AstraZeneca AB, and DSM IP Assets BV.

What are the main research topics associated with Flanin in the academic literature?

The primary research topics include bioluminescence and chemiluminescence research, photosynthetic processes and mechanisms, amino acid enzymes and metabolism, pharmacogenetics and drug metabolism, and enzyme structure and function.

Who are the most prolific authors publishing on Flanin-related research?

Gordon Tollin from the University of Arizona leads with 37 papers, followed by Stephen G. Mayhew from University College Dublin with 35 papers and Adelbert Bacher from Technical University of Munich with 25 papers. Other significant contributors include Vincent Massey and J. Woodland Hastings.

What patent classifications dominate the Flanin patent landscape?

The most prevalent CPC subclass is A61K (pharmaceuticals and medicinal preparations) with 5,948 patents, followed by A61P (specific therapeutic activity of chemical compounds) with 4,852 patents and C12N (microorganism or enzyme technology) with 4,361 patents. These classifications reflect the compound's applications in pharmaceutical and biotechnological fields.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial